EUVIMEDEUVIMED entdecken
Crossref

Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients

Kyungmin Huh iD, Minsun Kang iD, Young-Eun Kim iD, Yoonkyung Choi iD, Soo Jeong An iD, Jaehyun Seong iD, Min Jin Go, Ji-Man Kang iD, Jaehun Jung iD

The Journal of Infectious Diseases · 12.04.2024 · 229 (4) · 1026-1034

DOI: 10.1093/infdis/jiad501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 14.12.2023. Verfasst von Kyungmin Huh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: COVID-19, Organ Transplantation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety, National Institute of Infectious Diseases, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Solid organ transplant recipients (SOTRs) are at higher risk for severe infection. However, the risk for severe COVID-19 and vaccine effectiveness among SOTRs remain unclear.

Methods

This retrospective study used a nationwide health care claims database and COVID-19 registry from the Republic of Korea (2020 to 2022). Adult SOTRs diagnosed with COVID-19 were matched with up to 4 non-SOTR COVID-19 patients by propensity score. Severe COVID-19 was defined as treatment with high-flow nasal cannulae, mechanical ventilation, or extracorporeal membrane oxygenation.

Results

Among 6783 SOTRs with COVID-19, severe COVID-19 was reported with the highest rate in lung transplant recipients (13.16%), followed by the heart (6.30%), kidney (3.90%), and liver (2.40%). SOTRs had a higher risk of severe COVID-19 compared to non-SOTRs, and lung transplant recipients showed the highest risk (adjusted odds ratio, 18.14; 95% confidence interval [CI], 8.53–38.58). Vaccine effectiveness against severe disease among SOTRs was 47% (95% CI, 18%–65%), 64% (95% CI, 49%–75%), and 64% (95% CI, 29%–81%) for 2, 3, and 4 doses, respectively.

Conclusions

SOTRs are at significantly higher risk for severe COVID-19 compared to non-SOTRs. Vaccination is effective in preventing the progression to severe COVID-19. Efforts should be made to improve vaccine uptake among SOTRs, while additional protective measures should be developed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Organ TransplantationAdultHumansRetrospective StudiesTransplant RecipientsVaccination

Stichwörter der Autor:innen

COVID-19big dataorgan transplantationvaccines

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
  • Department of Bigdata Strategy, National Health Insurance Service, Wonju, South Korea.
  • Department of Big Data Management, National Health Insurance Service, Wonju, South Korea.
  • Division of Clinical Research, Center for Emerging Virus Research, National Institute of Infectious Disease, National Institute of Health, Osong, South Korea.
  • Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, South Korea.

ORCID-Profile: Kyungmin Huh, Minsun Kang, Young-Eun Kim, Yoonkyung Choi, Soo Jeong An, Jaehyun Seong, Ji-Man Kang, Jaehun Jung

Förderung

  • Ministry of Food and Drug Safety
  • National Institute of Infectious Diseases
  • National Institute of Health
  • National Institute of Health of the Republic of Korea

Zitieren

APA

Huh, K., Kang, M., Kim, Y. E., Choi, Y., An, S. J., Seong, J., Go, M. J., Kang, J. M., & Jung, J. (2024). Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients. The Journal of Infectious Diseases, 229(4), 1026-1034. https://doi.org/10.1093/infdis/jiad501

Vancouver

Huh K, Kang M, Kim YE, Choi Y, An SJ, Seong J, et al. Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients. The Journal of Infectious Diseases. 2024;229(4):1026-1034. doi:10.1093/infdis/jiad501

BibTeX
@article{Huh2024,
  author = {Huh, Kyungmin and Kang, Minsun and Kim, Young-Eun and Choi, Yoonkyung and An, Soo Jeong and Seong, Jaehyun and Go, Min Jin and Kang, Ji-Man and Jung, Jaehun},
  title = {Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {229},
  number = {4},
  pages = {1026--1034},
  doi = {10.1093/infdis/jiad501}
}
Kostenlos starten →